BETA nonprofit public democratic european moderated

Search

#LifeSciences

Blending together dozens of ingredients, researchers at the University of Minnesota have synthesized simple cells that feed, grow, reproduce, compete with one another for food. If these cells are not yet fully alive, they have most of the hallmarks of life https://t.co/XS2I8mzpTg #SyntheticBiology #LifeSciences #MinnesotaResearch #Therearenospecificcountrycodespresentinthetweet.

We discussed priorities for the EU Trade Council, including progress on free trade agreements, the EU–US trade relationship, and advancing the Life Sciences Strategic Task Force that Ireland has called for. https://t.co/aCS1zS0HSH #EUTradeCouncil #FreeTrade #LifeSciences #EU #US #IE

We discussed priorities for the EU Trade Council, including progress on free trade agreements, the EU–US trade relationship, & advancing the Life Sciences Strategic Task Force that Ireland has called for. #EUTradeCouncil #FreeTrade #LifeSciences #EU #US #IE

Top medicine secures quality of life and improves health: Bavaria is investing massively in high-tech and heart medicine. We want to become the number 1 life science location in Germany and all of Europe. Innovation and research are a priority for us. Today was (translated)

Biotech can change the future of medicine. Good meeting this week with @karlnehammer, @EIB Group VP for Life Sciences & TechEU, on #BioTechEU: €10bn for biotech to help innovation grow in Europe and reach patients faster. Learn more here: https://t.co/BZBGM8D8LZ https://t.co/d7aAZ4kB1u #Biotech #Innovation #LifeSciences #EU #AT

BBC May 2

AstraZeneca has announced a £300 million investment in UK drug development, reversing a previous decision to pause investment in Cambridge, which is expected to boost local employment and enhance patient access to clinical trials, amid changes in pharmaceutical pricing agreements between the UK and US. #PharmaceuticalIndustry #Investment #LifeSciences #UK #US

What does AstraZeneca's £300m pledge for UK mean for Cambridge?